Systemic Corticosteroids Avoidance Study in Severe Asthma Patients
Clinical trial NCT03629249 · TERMINATED
Trial details
- NCT number
- NCT03629249
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-13
- Primary completion
- 2020-02-06
- Enrollment
- 604
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.